We use cookies for a better user experience. Read our Privacy Policy
I Agree
Drug Discovery Outsourcing Market
Over the past decade, due to increasing competition, players involved in the biotech and pharmaceutical sector are primarily focusing on research and development activities to gain a competitive edge. In addition, economic environment, along with fast-paced developments on the technological front have accelerated internal as well as external innovations in the pharmaceutical space due to which, drug discovery outsourcing has gained considerable traction. External innovations largely occur in various forms at various places, including research laboratories, university labs, contract research organizations, and venture capital-based startups.
Over the past couple of decades, various challenges within the pharmaceutical sector have been well documented and point toward few key areas. The development of new drugs continues to head toward steep costs, the market competition from generics continues to grow, investors expect higher returns, and rising consumer complaints regarding high costs of drugs have led to the growth of the drug discovery outsourcing. This trend is likely to continue during the forecast period. Pharmaceutical companies are increasingly focusing on improving the efficacy of drug development and discovery.
Major developments that are likely to gain considerable traction over the next few years across the drug discovery outsourcing market include a decline in time utilized for drug development, improving the conversion rate of hits to leads, and expanding the number of high-quality compounds. At the back of these factors and evolving economic landscape, the global drug discovery outsourcing market is expected to reach ~US$ 12.7 Bn by the end of 2030.
To know the scope of our report Get a Sample on Drug Discovery Outsourcing Market
Biotech and pharmaceutical companies have consistently expressed high levels of interest in drug discovery outsourcing due to immense cost saving and various other benefits over in-house manufacturing. As per current trends, the number of small and medium-sized businesses operating in the drug discovery outsourcing market is expected to remain higher than that of larger entities due to the low number of stakeholders and fewer organizational barriers in decision-making. In addition, apart from minimizing organizational complications, small and medium-sized companies are increasingly relying on drug discovery outsourcing for product manufacturing and development due to various factors, including insufficient production ability and lack of technical expertise. These factors, along with mushrooming costs of research and development activities continue to accelerate the overall growth of the global drug discovery outsourcing market.
The modern-day pharmaceutical is marred with several challenges in the drug development phase and requires considerable changes. Due to mounting challenges in drug development, drug development as well as drug discovery activities are increasingly being outsourced. Pricing pressure remains the major factor that is likely to trigger the tectonic shift in drug discovery outsourcing during the forecast period. High profit margins of pharmaceutical companies have attracted the attention of healthcare providers to add pressure pertaining to costs and reimbursement. In addition, as a result, as profit margins continue to decline several companies are evaluating the possibility of outsourcing drug discovery to third party organizations that have been equipped with required resources.
Get a glimpse of the in-depth analysis through our Report Brochure
Technological advancements have played a key role in accelerating innovations in the past decade and the trend is likely to continue in the upcoming decade. Due to fast-paced development in technology, competition in the drug discovery and drug development sectors has increased at a rapid pace. Due to the cutthroat competition, several companies in the drug discovery outsourcing market are increasingly joining hands with third-party companies to develop various cost-effective drugs.
The ongoing COVID-19 pandemic is expected to have a low impact on the overall prospects of the global drug discovery outsourcing market. In addition, the outsourcing of drugs and medications required to manage COVID-19 infections is expected to witness considerable growth during the COVID-19 pandemic. Pharmaceutical companies are likely to turn toward domestic players for drug discovery outsourcing rather than businesses based in other regional markets. Logistical challenges, along with trade restrictions could possibly pose a barrier in the supply chain.
In addition, as the number of COVID-19 patients continues to swell around the world, pharmaceutical companies are increasingly relying on drug discovery outsourcing to fulfill the soaring demand. Several companies are expected to invest resources in research and development activities that focus on the discovery of a vaccine for the COVID-19 coronavirus. The ongoing investments in research coupled with high demand for medication to treat COVID-19 patients is expected to play a key role in boosting the growth of the drug discovery outsourcing market during the COVID-19 pandemic.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The global drug discovery outsourcing market is expected to grow at an impressive CAGR of 10% during the forecast period. The market growth can be attributed to increase in research and development costs, rise in competition in the pharmaceutical sector, consumer demand for low-cost and efficient medication, and advancements in technology. Small to medium-sized pharmaceutical companies are increasingly turning to drug discovery outsourcing due to lack of adequate production capabilities & resources and lack of expertise. Although several larger companies are also expected to follow a similar path, organizational complications and discrepancies among shareholders could possibly slow down the process.
Drug Discovery Outsourcing Market – Segmentation
|
Service Type |
Biological Services Chemical Services Lead Identification & Screening Lead Optimization Others |
|
Drug Type |
Small Molecules Large Molecules |
|
Therapeutic Area |
Respiratory System Anti-infective Oncology Cardiovascular Gastrointestinal Central Nervous System Immunomodulation Others |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
Drug discovery outsourcing market is expected to reach ~US$ 12.7 Bn by the end of 2030
North America dominated the global drug discovery outsourcing market in 2019, and the trend is expected to continue during the forecast period
Drug Discovery Outsourcing Market is driven by rise in penetration of contract research organizations for pre-clinical research, increase in investments in research and development (R&D) and a surge in the demand for personalized medicines
The small molecules segment is anticipated to account for a major share of the global drug discovery outsourcing market during the forecast period
Key players operating in the global drug discovery outsourcing market are CHARLES RIVER LABORATORIES INTERNATIONAL, INC., WuXi AppTec Co., Ltd., Albany Molecular Research Inc. (AMRI), GVK Biosciences Private Limited, Sygnature Discovery
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug Discovery Outsourcing Market
4. Market Overview
4.1. Definition
4.2. Market Indicators
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030
4.5. Global Drug Discovery Outsourcing Market Outlook
5. Key Insights
5.1. Key Mergers & Acquisition
5.2. Technological Advancements in Drug Discovery
5.3. Drug Discovery Process – an Overview
5.4. COVID-19 Pandemics Impact on Drug Discovery Outsourcing Industry
5.5. Overview of Companies outsourcing to CROs
5.6. Overview: Integrated Drug Discovery (IDD) outsourcing- trends, competition, business models preferred, type of projects outsourced
6. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Service Type
6.1. Introduction
6.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type
6.3. Global Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
6.3.1. Biological Services
6.3.2. Chemical Services
6.3.3. Lead Identification & Screening
6.3.4. Lead Optimization
6.3.5. Others
6.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type
7. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Drug Type
7.1. Introduction
7.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type
7.3. Global Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
7.3.1. Small Molecules
7.3.2. Large Molecules
7.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type
8. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Therapeutic Area
8.1. Introduction
8.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area
8.3. Global Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
8.3.1. Respiratory System
8.3.2. Anti-infective
8.3.3. Oncology
8.3.4. Cardiovascular
8.3.5. Gastrointestinal
8.3.6. Central Nervous System
8.3.7. Immunomodulation
8.3.8. Others
8.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area
9. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Region
9.1. Regional Outlook
9.2. Introduction
9.3. Global Drug Discovery Outsourcing Market Value Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region
10. North America Drug Discovery Outsourcing Market Analysis and Forecast
10.1. Key Findings
10.2. North America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
10.2.1. Biological Services
10.2.2. Chemical Services
10.2.3. Lead Identification & Screening
10.2.4. Lead Optimization
10.2.5. Others
10.3. North America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
10.3.1. Small Molecules
10.3.2. Large Molecules
10.4. North America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
10.4.1. Respiratory System
10.4.2. Anti-infective
10.4.3. Oncology
10.4.4. Cardiovascular
10.4.5. Gastrointestinal
10.4.6. Central Nervous System
10.4.7. Immunomodulation
10.4.8. Others
10.5. North America Drug Discovery Outsourcing Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Drug Discovery Outsourcing Market Attractiveness Analysis
10.6.1. By Service Type
10.6.2. By Drug Type
10.6.3. By Therapeutic Area
10.6.4. By Country
11. Europe Drug Discovery Outsourcing Market Analysis and Forecast
11.1. Key Findings
11.2. Europe Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
11.2.1. Biological Services
11.2.2. Chemical Services
11.2.3. Lead Identification & Screening
11.2.4. Lead Optimization
11.2.5. Others
11.3. Europe Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
11.3.1. Small Molecules
11.3.2. Large Molecules
11.4. Europe Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
11.4.1. Respiratory System
11.4.2. Anti-infective
11.4.3. Oncology
11.4.4. Cardiovascular
11.4.5. Gastrointestinal
11.4.6. Central Nervous System
11.4.7. Immunomodulation
11.4.8. Others
11.5. Europe Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Drug Discovery Outsourcing Market Attractiveness Analysis
11.6.1. By Service Type
11.6.2. By Drug Type
11.6.3. By Therapeutic Area
11.6.4. By Country/Sub-region
12. Asia Pacific Drug Discovery Outsourcing Market Analysis and Forecast
12.1. Key Findings
1.1. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
12.1.1. Biological Services
12.1.2. Chemical Services
12.1.3. Lead Identification & Screening
12.1.4. Lead Optimization
12.1.5. Others
12.2. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
12.2.1. Small Molecules
12.2.2. Large Molecules
12.3. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
12.3.1. Respiratory System
12.3.2. Anti-infective
12.3.3. Oncology
12.3.4. Cardiovascular
12.3.5. Gastrointestinal
12.3.6. Central Nervous System
12.3.7. Immunomodulation
12.3.8. Others
12.4. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030
12.4.1. China
12.4.2. India
12.4.3. Japan
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis
12.5.1. By Service Type
12.5.2. By Drug Type
12.5.3. By Therapeutic Area
12.5.4. By Country/Sub-region
13. Latin America Drug Discovery Outsourcing Market Analysis and Forecast
13.1. Key Findings
13.2. Latin America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
13.2.1. Biological Services
13.2.2. Chemical Services
13.2.3. Lead Identification & Screening
13.2.4. Lead Optimization
13.2.5. Others
13.3. Latin America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
13.3.1. Small Molecules
13.3.2. Large Molecules
13.4. Latin America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
13.4.1. Respiratory System
13.4.2. Anti-infective
13.4.3. Oncology
13.4.4. Cardiovascular
13.4.5. Gastrointestinal
13.4.6. Central Nervous System
13.4.7. Immunomodulation
13.4.8. Others
13.5. Latin America Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis
13.6.1. By Service Type
13.6.2. By Drug Type
13.6.3. By Therapeutic Area
13.6.4. By Country/Sub-region
14. Middle East & Africa Drug Discovery Outsourcing Market Analysis and Forecast
14.1. Key Findings
14.2. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
14.2.1. Biological Services
14.2.2. Chemical Services
14.2.3. Lead Identification & Screening
14.2.4. Lead Optimization
14.2.5. Others
14.3. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
14.3.1. Small Molecules
14.3.2. Large Molecules
14.4. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
14.4.1. Respiratory System
14.4.2. Anti-infective
14.4.3. Oncology
14.4.4. Cardiovascular
14.4.5. Gastrointestinal
14.4.6. Central Nervous System
14.4.7. Immunomodulation
14.4.8. Others
14.5. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis
14.6.1. By Service Type
14.6.2. By Drug Type
14.6.3. By Therapeutic Area
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2019
15.3. Company Profiles
15.3.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. WuXi AppTec Co., Ltd.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. Albany Molecular Research Inc. (AMRI)
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. GVK Biosciences Private Limited
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. Sygnature Discovery
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. Pharmaron Beijing Co., Ltd.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. WuXi Biologics (Cayman), Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
15.3.8. Domainex Ltd.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis
15.3.9. Thermo Fisher Scientific, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Strategic Overview
15.3.9.5. SWOT Analysis
15.3.10. Jubilant Biosys Ltd.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Financial Overview
15.3.10.3. Product Portfolio
15.3.10.4. Strategic Overview
15.3.10.5. SWOT Analysis
15.3.11. Evotec SE
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. Strategic Overview
15.3.11.5. SWOT Analysis
15.3.12. Eurofins Discovery
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Financial Overview
15.3.12.3. Product Portfolio
15.3.12.4. Strategic Overview
15.3.12.5. SWOT Analysis
15.3.13. GenScript Biotech Corporation
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Financial Overview
15.3.13.3. Product Portfolio
15.3.13.4. Strategic Overview
15.3.13.5. SWOT Analysis
List of Tables
Table 01: Companies entering into partnerships with CROs for drug discovery
Table 02: Integrated Drug Discovery – Key Players
Table 03: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 04: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 05: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
Table 06: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 07: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 08: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 09: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 10: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
Table 11: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 12: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 13: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 14: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
Table 15: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 16: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 17: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 18: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
Table 19: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 20: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 21: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 22: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
Table 23: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 24: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 25: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 26: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
List of Figures
Figure 01: Global Drug Discovery Outsourcing Market
Figure 02: Global Drug Discovery Outsourcing Market Size (US$ Mn) Forecast, 2018–2030
Figure 03: Global Drug Discovery Outsourcing market Value Share, by Service Type, 2020
Figure 04: Global Drug Discovery Outsourcing Market Value Share, by Drug Type, 2020
Figure 05: Global Drug Discovery Outsourcing Market Value Share, by Therapeutic Area, 2020
Figure 06: Global Drug Discovery Outsourcing Market Value Share, by Region, 2020
Figure 07: CRO Services Market – Key Mergers and Acquisitions
Figure 08: Technological Advancements in Drug Discovery
Figure 09: Drug Discovery & Development Process – an Overview
Figure 10: Drug Discovery Process – an Overview
Figure 11: IDD Trends
Figure 12: IDD Business Models
Figure 13: IDD- Types of Projects
Figure 14: Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 15: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030
Figure 16: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biological Services, 2018–2030
Figure 17: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chemical Services, 2018–2030
Figure 18: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lead Identification & Screening, 2018–2030
Figure 19: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lead Optimization, 2018–2030
Figure 20: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030
Figure 21: Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 22: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type, 2020–2030
Figure 23: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Small Molecules, 2018–2030
Figure 24: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Large Molecules, 2018–2030
Figure 25: Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
Figure 26: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2020–2030
Figure 27: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Respiratory System, 2018–2030
Figure 28: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Anti-infective, 2018–2030
Figure 29: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oncology, 2018–2030
Figure 30: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiovascular, 2018–2030
Figure 31: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gastrointestinal, 2018–2030
Figure 32: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Central Nervous System, 2018–2030
Figure 33: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Immunomodulation, 2018–2030
Figure 34: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030
Figure 35: Global Drug Discovery Outsourcing Market: Regional Outlook
Figure 36: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030
Figure 37: Global Drug Discovery Outsourcing Market Value Share Analysis, by Region, 2019 and 2030
Figure 38: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region, 2020–2030
Figure 39: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030
Figure 40: North America Drug Discovery Outsourcing Market Value Share Analysis, by Country, 2019 and 2030
Figure 41: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country, 2020–2030
Figure 42: North America Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 43: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030
Figure 44: North America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 45: North America Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030
Figure 46: North America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
Figure 47: North America Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030
Figure 48: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030
Figure 49: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 50: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 51: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 52: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030
Figure 53: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 54: Europe Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030
Figure 55: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
Figure 56: Europe Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030
Figure 57: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030
Figure 58: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 59: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 60: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 61: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030
Figure 62: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 63: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type, 2020–2030
Figure 64: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
Figure 65: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2020–2030
Figure 66: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030
Figure 67: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 68: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 69: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 70: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030
Figure 71: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 72: Latin America Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030
Figure 73: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
Figure 74: Latin America Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030
Figure 75: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030
Figure 76: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 77: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 78: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 79: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030
Figure 80: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 81: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030
Figure 82: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030
Figure 83: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030
Figure 84: Global Drug Discovery Outsourcing Market Analysis, by Top Company Ranking, 2019
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes